Emergent BioSolutions' Q3 earnings report drives 20% surge in share price, reflecting market optimism. See why award a ...

My name is Chris, and I will be your conference operator today. At this time, I would like to welcome everyone to the Q3 2024 ...

Emergent Biosolutions ( (EBS) ) has released its Q3 earnings. Here is a breakdown of the information Emergent Biosolutions presented to its ...

Reports Q3 revenue $293.8M vs. $270.5M last year. “Through disciplined execution and steady, measurable progress, Emergent’s ...

Emergent BioSolutions Inc (EBS) reports a robust financial performance with a 9% revenue increase and significant debt reduction, despite challenges in Narcan sales.

GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Wednesday reported profit of $114.8 million in its third quarter. On a per-share basis, the Gaithersburg ...

Q3 2024 Earnings Call Transcript November 6, 2024 Emergent BioSolutions Inc. beats earnings expectations. Reported EPS is ...

At this time, I would like to welcome everyone to the Q3 2024 Emergent BioSolutions Inc. earnings conference call. All lines have been placed on mute to prevent any background noise. After the ...

At this time, I would like to welcome everyone to the Q3 2024 Emergent BioSolutions Inc. Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the ...